Tandem Diabetes Care earnings were -$94.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest TNDM earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$20.4M, up 3,362.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TNDM reported annual earnings of -$204.7M, with 113.2% growth.
Tandem Diabetes Care Earnings Reports & History FAQ
What were Tandem Diabetes Care's earnings last quarter?
On TNDM's earnings call on Invalid Date, Tandem Diabetes Care (NASDAQ: TNDM) reported Q1 2026 earnings per share (EPS) of -$0.30, up 84.77% year over year. Total TNDM earnings for the quarter were -$20.39 million. In the same quarter last year, Tandem Diabetes Care's earnings per share (EPS) was -$1.97.
Is Tandem Diabetes Care profitable or losing money?
As of the last Tandem Diabetes Care earnings report, Tandem Diabetes Care is currently losing money. Tandem Diabetes Care's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$94.55 million, a 48.58% decrease year over year.
What was TNDM's earnings growth in the past year?
As of Tandem Diabetes Care's earnings date in Invalid Date, Tandem Diabetes Care's earnings has grown year over year. TNDM earnings in the past year totalled -$94.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.